Companies: 10,795·Total market cap: $144.5T
BioAge Labs, Inc.

BioAge Labs, Inc.

BIOANASDAQHealthcare● Active
$15.51
$-0.19(-1.21%)
Market Cap$583945839
P/E Ratio
52W High$24
52W Low$4.065

BioAge Labs, Inc. (BIOA) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

bioa · stock forecast · 3 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 3 Wall Street analysts in the past 3 months

SellBuy

Buy

3 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
Total: 3 · Buy rate: 66.7%

12-Month Price Target

High

$62.00

Consensus

$42.20

+172.1% upside

Low

$23.00

Median: $40 · Last Close: $15.51

The BioAge Labs, Inc. (BIOA) analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month BIOA price target is $42.20, representing +172.1% upside from the current price of $15.51.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $42 (172.1%)

Consensus Target

$42.20

172.1% upside

High Target

$62

299.7%

Low Target

$23

48.3%

Current Price

$15.51

as of today

Based on analyst price targets, the BIOA stock price prediction for the next 12 months ranges from $23 to $62. The consensus BIOA price forecast of $42.20 implies 172.1% upside from the current price of $15.51.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$15.023.18%

1-day model range: $14.89–$15.14. Peak: $15.14 (-3.18%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$21+36.4%
2028$25+63.7%
2029$28+81.7%
2030$30+92.7%
2031+99.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)51.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · BIOA · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$16.16SELL
MA 10$16.55SELL
MA 20$16.93SELL
MA 50$17.20SELL
MA 100$18.63SELL
MA 200$13.46BUY
Current $BIOA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$16.10SELL
EMA 10$16.41SELL
EMA 20$16.74SELL
EMA 50$17.25SELL
EMA 100$16.74SELL
EMA 200$14.27BUY
Current $BIOA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citigroup2026-03-10
Maintains
BuyBuy
Jefferies2026-02-18
Upgrade ↑
HoldBuy
Morgan Stanley2025-12-08
Upgrade ↑
UnderweightEqual Weight
Citigroup2025-10-29
Maintains
BuyBuy
Citigroup2025-10-22
Upgrade ↑
NeutralBuy
Citigroup2025-03-24
Maintains
NeutralNeutral
Citigroup2024-12-09
Downgrade ↓
BuyNeutral
Jefferies2024-12-09
Downgrade ↓
BuyHold

Wall Street analysts have recently issued updated ratings on BioAge Labs, Inc. (BIOA) stock. Of the recent 8 rating actions, 3 were upgrades and 2 were downgrades. 3 analysts currently cover BIOA.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings202
Sell ratings00

BIOA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$6M

↑ 88.5% YoY

Revenue Next Year

$35M

↑ 490.3% YoY

EPS This Year

$-2.61

EPS Next Year

$-1.95

↓ 25.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BIOA EPS of $-2.61 for the current fiscal year, based on estimates from 6 analysts. The BIOA revenue forecast is $6M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BIOA stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BIOA price target is $42.20 (+172.1% upside), with an analyst consensus of Buy.

The BIOA short-term stock prediction for tomorrow is $15.02 (-3.18%). The BIOA stock price prediction for 2027 estimates an average of $21. The BIOA stock prediction for 2030 projects a range of $27–$33.

BioAge Labs, Inc. trades on NASDAQ under the ticker BIOA. The BIOA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BIOA forecast · 8 questions

According to 3 Wall Street analysts, the average 12-month BIOA price target is $42.20, with a high forecast of $62.00 and a low of $23.00. The median price target is shown in the chart above when available. This implies +172.1% potential upside from the current price of $15.51.

BIOA price targetWhat is BIOA price targetBIOA analyst price targetBIOA 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.